NYSE:HLN

Haleon (HLN) Stock Forecast, Price & News

$8.06

-0.01 (-0.12%)

(As of 05/31/2023 ET)

Compare

Today's Range: $7.99
▼
$8.09
50-Day Range: $8.07
▼
$9.00
52-Week Range: $5.59
▼
$9.05

Volume: 2.19 million shs
Average Volume: 4.53 million shs
Market Capitalization: $37.24 billion

P/E Ratio: N/A
Dividend Yield: 0.74%
Price Target: N/A

Haleon MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.39% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.44
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 6.52%
From $0.46 to $0.49 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.26 out of 5 stars

Medical Sector

972nd out of 1,006 stocks

Toilet Preparations Industry

11th out of 11 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Haleon.

3.0

Short Interest

Percentage of Shares Shorted
0.39% of the float of Haleon has been sold short.
Short Interest Ratio / Days to Cover
Haleon has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month

0.8

Dividend Strength

Dividend Yield
Haleon has a dividend yield of 0.72%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Haleon does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Haleon will have a dividend payout ratio of 12.24% next year. This indicates that Haleon will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HLN.

2.5

News and Social Media Coverage

News Sentiment
Haleon has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Haleon this week, compared to 2 articles on an average week.
Search Interest
Only 8 people have searched for HLN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
8 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is an increase of 60% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Haleon insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 6.67% of the stock of Haleon is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Haleon are expected to grow by 6.52% in the coming year, from $0.46 to $0.49 per share.
Price to Earnings Growth Ratio
Haleon has a PEG Ratio of 2.58. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Haleon has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Haleon (NYSE:HLN) Stock

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

HLN Stock News Headlines

May 30, 2023 | americanbankingnews.com

Yatsen (NYSE:YSG) vs. Haleon (NYSE:HLN) Head-To-Head Comparison

May 26, 2023 | americanbankingnews.com

Stifel Nicolaus Begins Coverage on Haleon (NYSE:HLN)

June 1, 2023 | Behind the Markets (Ad)

WARNING: Do You Invest with these Banks

Take a close look at the investment banks above. Because if you have stocks with any of these brokerages... These new political developments WILL affect you.

May 24, 2023 | wsj.com

Haleon PLC

May 24, 2023 | americanbankingnews.com

Haleon plc (NYSE:HLN) Receives $364.00 Consensus Price Target from Brokerages

May 12, 2023 | msn.com

GSK cuts its Haelon stake in $1B share sale

May 5, 2023 | seekingalpha.com

Haleon: Brand Portfolio Strength Keeps Us Bullish

May 1, 2023 | americanbankingnews.com

Haleon plc (NYSE:HLN) Receives $364.00 Consensus Target Price from Analysts

June 1, 2023 | Behind the Markets (Ad)

WARNING: Do You Invest with these Banks

Take a close look at the investment banks above. Because if you have stocks with any of these brokerages... These new political developments WILL affect you.

April 30, 2023 | americanbankingnews.com

Haleon (NYSE:HLN) and United-Guardian (NASDAQ:UG) Financial Comparison

April 19, 2023 | proactiveinvestors.com

Haleon profit margin may disappoint, says Barclays

April 15, 2023 | americanbankingnews.com

FY2024 EPS Estimates for Haleon plc (NYSE:HLN) Cut by Analyst

April 7, 2023 | americanbankingnews.com

Haleon (NYSE:HLN) Upgraded by Argus to Buy

April 6, 2023 | americanbankingnews.com

Haleon (NYSE:HLN) Shares Gap Up to $8.17

April 6, 2023 | americanbankingnews.com

Sanford C. Bernstein Initiates Coverage on Haleon (NYSE:HLN)

February 6, 2023 | finance.yahoo.com

Haleon plc's (LON:HLN) largest shareholders are public companies with 45% ownership, institutions own 42%

January 19, 2023 | finance.yahoo.com

Is This the Time to Add Haleon plc (HLN) to Your Portfolio?

November 16, 2022 | insidermonkey.com

Ken Fisher Strategy: 5 New Stock Picks

November 13, 2022 | finance.yahoo.com

Haleon Reports Third Quarter 2022 Earnings

November 9, 2022 | finance.yahoo.com

Should You Invest in Haleon plc (HLN)?

October 19, 2022 | finance.yahoo.com

An Intrinsic Calculation For Haleon plc (LON:HLN) Suggests It's 34% Undervalued

October 18, 2022 | barrons.com

Johnson & Johnson Earnings Top Estimates. Its CFO Explains What Went Right. - Barron's

October 13, 2022 | uk.finance.yahoo.com

Is the Haleon share price cheap under £3 ahead of earnings? - Yahoo Finance UK

October 11, 2022 | proactiveinvestors.com

Haleon PLC sales targets impress Barclays - Proactive Investors USA

October 4, 2022 | investing.com

The Bullish Case For GlaxoSmithKline At Current Levels - Investing.com

September 30, 2022 | prnewswire.com

Haleon plc Announces Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK - PR Newswire

September 29, 2022 | finance.yahoo.com

Haleon plc Announces Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK - Yahoo Finance

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

HLN Company Calendar

Ex-Dividend for 4/27 Dividend: 3/16/2023
Dividend Payable: 4/27/2023
Today: 5/31/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Toilet preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:HLN
CUSIP: N/A
CIK: 1900304
Web: www.haleon.com
Phone: 44-19-3282-2000
Fax: N/A
Employees: 24,622
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 17.50
P/E Growth: 2.58
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.61
Current Ratio: 0.93
Quick Ratio: 0.62

Sales & Book Value

Annual Sales: $13.43 billion
Price / Sales: 2.77
Cash Flow: $0.35 per share
Price / Cash Flow: 22.89
Book Value: $4.41 per share
Price / Book: 1.83

Miscellaneous

Outstanding Shares: 4,617,290,000
Free Float: N/A
Market Cap: $37.17 billion
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Brian McNamara (Age 55)
CEO & Exec. Director

Mr. Tobias Hestler (Age 50)
CFO & Exec. Director

Ms. Amy Landucci
Head of Digital and Technology

Mr. Bjarne Philip Tellmann (Age 55)
Gen. Counsel

Ms. Tamara Rogers (Age 53)
Chief Marketing Officer

Ms. Mairead Nayager (Age 47)
Chief HR Officer

Mr. Bart Derde (Age 53)
Head of Quality and Supply Chain

Mr. Filippo Lanzi
Head of EMEA & LatAm

Ms. Teri Lyng (Age 60)
Head of Transformation & Sustainability

Ms. Jooyong Lee (Age 45)
Head of Strategy and Office of the CEO

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

HLN Stock - Frequently Asked Questions

Should I buy or sell Haleon stock right now?: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 sell ratings, 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares.
View HLN analyst ratings or view top-rated stocks.
How have HLN shares performed in 2023?: Haleon's stock was trading at $8.00 at the beginning of 2023. Since then, HLN stock has increased by 0.6% and is now trading at $8.05.
View the best growth stocks for 2023 here.
How often does Haleon pay dividends? What is the dividend yield for Haleon?: Haleon announced a -- dividend on Thursday, March 2nd. Stockholders of record on Friday, March 17th will be paid a dividend of $0.0577 per share on Thursday, April 27th. This represents a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, March 16th.
Read our dividend analysis for HLN.
What ETFs hold Haleon's stock?: ETFs with the largest weight of Haleon (NYSE:HLN) stock in their portfolio include VanEck Pharmaceutical ETF (PPH), Pacer BioThreat Strategy ETF (VIRS), ClearBridge Focus Value ESG ETF (CFCV) and Horizon Kinetics Medical ETF (MEDX).BlackRock Future Health ETF (BMED),
Is Haleon a good dividend stock?: Haleon (NYSE:HLN) pays an annual dividend of $0.06 per share and currently has a dividend yield of 0.72%.
Read our dividend analysis for HLN.
What is Haleon's stock symbol?: Haleon trades on the New York Stock Exchange (NYSE) under the ticker symbol "HLN."

Who are Haleon's major shareholders?: Haleon's stock is owned by many different retail and institutional investors. Top institutional shareholders include Dodge & Cox (2.43%), FMR LLC (0.66%), Clearbridge Investments LLC (0.55%), Fisher Asset Management LLC (0.37%), Bain Capital Public Equity Management II LLC (0.28%) and Harding Loevner LP (0.21%).
How do I buy shares of Haleon?: Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Haleon's stock price today?: One share of HLN stock can currently be purchased for approximately $8.05.
How much money does Haleon make?: Haleon (NYSE:HLN) has a market capitalization of $37.17 billion and generates $13.43 billion in revenue each year.
How many employees does Haleon have?: The company employs 24,622 workers across the globe.
How can I contact Haleon?: The official website for the company is www.haleon.com. The company can be reached via phone at 44-19-3282-2000 or via email at investor-relations@haleon.com.

This page (NYSE:HLN) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial